A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome | MicrobiomeTrials
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-12-11Est. Completion: 2028-03
Enrollment target: 300 participants
Locations
Clinical Research Institute of Arizona, Sun City West, Arizona, United States
Scripps Health - Whittier Diabetes Institute, La Jolla, California, United States
UC SanDiego Health, La Jolla, California, United States
Western University of Health Sciences, Pomona, California, United States
UF Health Jackson, Jacksonville, Florida, United States
East Coast Institute of Research LLC, Jacksonville, Florida, United States
East Coast Institute of Research LLC, Lake City, Florida, United States
K2 Medical Research, Maitland, Florida, United States
Floridian Clinical Research, Miami Lakes, Florida, United States
Cardiovascular Center of Sarasote Foundation for Research and Education, Sarasota, Florida, United States
High Desert Heart, Meridian, Idaho, United States
Endeavour Health, Skokie, Illinois, United States
Louisville Metabolic and Atherosclerosis Research Center (L-MARC), Louisville, Kentucky, United States
Eastern Maine Medical Center, Bangor, Maine, United States
MD Medical Research, Oxon Hill, Maryland, United States
Other microbiome trials you might be interested in
MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.
Jefferson City Medical Group, Jefferson City, Missouri, United States
Montana Medical Research, Missoula, Montana, United States
Inspira Health - Internal Medicine Associates, Bridgeton, New Jersey, United States
Central New York Clinical Research, Manlius, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Velocity Clinical Research, Durham, North Carolina, United States
PharmQuest Life Sciences, LLC, Greensboro, North Carolina, United States
Centricity Research dba Lucas Research, Morehead City, North Carolina, United States
Summit Research Group, Munroe Falls, Ohio, United States
Diabetes & Glandular Disease Clinic, P.A., Kingsport, Tennessee, United States
Baylor College of Medicine - Center for Cardiometabolic Disease Prevention (The Center for Cardiovascular Disease Prevention), Houston, Texas, United States
Juno Research LLC - Medical Center, Houston, Texas, United States
PlanIt Research, PLLC, Houston, Texas, United States
Clinical Trials of Texas dba Flourish Research, San Antonio, Texas, United States
Burke Internal Medicine, Burke, Virginia, United States
Burke International Medicine DBA Manassas Clinical Research Center, Manassas, Virginia, United States
Universal Research Group, Tacoma, Washington, United States
Dien Servis s.r.o., Humpolec, Vysocina, Czechia
DOCTOR MN s.r.o, Čáslav, Czechia
MUDr. Alena Váchová, České Budějovice, Czechia
MEDIKA Hradec Králové, s.r.o., Hradec Králové, Czechia
Interni diabetologicka ambulance (Pratia), Jílové u Prahy, Czechia
Diabetologie - Dr. Tomas Edelsberger, Krnov, Czechia